Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
The U.S. Meals and Drug Administration (FDA) has authorised the usage of Darzalex Faspro (daratumumab and hyaluronidase-fihj) together with Velcade (bortezomib), Revlimid...
The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to bezuclastinib utilized in mixture with Sutent (sunitinib) for sufferers...
